chr6-32064966-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001365276.2(TNXB):​c.6696C>T​(p.Asp2232Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 1,612,086 control chromosomes in the GnomAD database, including 133,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11883 hom., cov: 31)
Exomes 𝑓: 0.40 ( 122050 hom. )

Consequence

TNXB
NM_001365276.2 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -4.29

Publications

37 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001365276.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-32064966-G-A is Benign according to our data. Variant chr6-32064966-G-A is described in ClinVar as Benign. ClinVar VariationId is 261150.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.28 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
NM_001365276.2
MANE Select
c.6696C>Tp.Asp2232Asp
synonymous
Exon 19 of 44NP_001352205.1P22105-3
TNXB
NM_001428335.1
c.7437C>Tp.Asp2479Asp
synonymous
Exon 20 of 45NP_001415264.1A0A3B3ISX9
TNXB
NM_019105.8
c.6696C>Tp.Asp2232Asp
synonymous
Exon 19 of 44NP_061978.6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
ENST00000644971.2
MANE Select
c.6696C>Tp.Asp2232Asp
synonymous
Exon 19 of 44ENSP00000496448.1P22105-3
TNXB
ENST00000647633.1
c.7437C>Tp.Asp2479Asp
synonymous
Exon 20 of 45ENSP00000497649.1A0A3B3ISX9
TNXB
ENST00000375244.7
TSL:5
c.6696C>Tp.Asp2232Asp
synonymous
Exon 19 of 44ENSP00000364393.3P22105-3

Frequencies

GnomAD3 genomes
AF:
0.381
AC:
57919
AN:
151920
Hom.:
11874
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.249
Gnomad AMI
AF:
0.602
Gnomad AMR
AF:
0.459
Gnomad ASJ
AF:
0.561
Gnomad EAS
AF:
0.451
Gnomad SAS
AF:
0.418
Gnomad FIN
AF:
0.481
Gnomad MID
AF:
0.433
Gnomad NFE
AF:
0.409
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.438
AC:
106625
AN:
243534
AF XY:
0.435
show subpopulations
Gnomad AFR exome
AF:
0.251
Gnomad AMR exome
AF:
0.554
Gnomad ASJ exome
AF:
0.567
Gnomad EAS exome
AF:
0.451
Gnomad FIN exome
AF:
0.473
Gnomad NFE exome
AF:
0.418
Gnomad OTH exome
AF:
0.419
GnomAD4 exome
AF:
0.404
AC:
589342
AN:
1460048
Hom.:
122050
Cov.:
69
AF XY:
0.405
AC XY:
294009
AN XY:
726294
show subpopulations
African (AFR)
AF:
0.251
AC:
8391
AN:
33476
American (AMR)
AF:
0.542
AC:
24176
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
0.557
AC:
14548
AN:
26128
East Asian (EAS)
AF:
0.451
AC:
17901
AN:
39686
South Asian (SAS)
AF:
0.400
AC:
34527
AN:
86232
European-Finnish (FIN)
AF:
0.461
AC:
24114
AN:
52280
Middle Eastern (MID)
AF:
0.417
AC:
2398
AN:
5756
European-Non Finnish (NFE)
AF:
0.395
AC:
439147
AN:
1111520
Other (OTH)
AF:
0.400
AC:
24140
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
22588
45176
67763
90351
112939
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13532
27064
40596
54128
67660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.381
AC:
57948
AN:
152038
Hom.:
11883
Cov.:
31
AF XY:
0.387
AC XY:
28749
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.249
AC:
10311
AN:
41486
American (AMR)
AF:
0.459
AC:
7020
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.561
AC:
1944
AN:
3468
East Asian (EAS)
AF:
0.452
AC:
2324
AN:
5142
South Asian (SAS)
AF:
0.417
AC:
2011
AN:
4828
European-Finnish (FIN)
AF:
0.481
AC:
5085
AN:
10578
Middle Eastern (MID)
AF:
0.432
AC:
126
AN:
292
European-Non Finnish (NFE)
AF:
0.409
AC:
27804
AN:
67948
Other (OTH)
AF:
0.368
AC:
775
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1764
3528
5292
7056
8820
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.400
Hom.:
5470
Bravo
AF:
0.378
Asia WGS
AF:
0.380
AC:
1323
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Ehlers-Danlos syndrome due to tenascin-X deficiency (1)
-
-
1
Vesicoureteral reflux 8 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.069
DANN
Benign
0.67
PhyloP100
-4.3
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs204883;
hg19: chr6-32032743;
COSMIC: COSV64487981;
COSMIC: COSV64487981;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.